CVS Health (CVS) Tops Q1 EPS by 36c; raises guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $102.16 +3.91%
Revenue Growth %: +1.2%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +1.2%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q1 EPS of $2.57, $0.36 better than the analyst estimate of $2.21. Revenue for the quarter came in at $100.4 billion versus the consensus estimate of $95.02 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.30-$7.50, versus the consensus of $7.16.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Apple investigating exposure to Tata Electronics data breach, full analysis underway - Reuters
- Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
